- Home
- NATR vs SERA Comparison
NATR vs SERA Comparison
Compare NATR & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- SERA
- Stock Information
- Founded
- NATR 1972
- SERA 2008
- Country
- NATR United States
- SERA United States
- Employees
- NATR N/A
- SERA N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- SERA Precision Instruments
- Sector
- NATR Health Care
- SERA Health Care
- Exchange
- NATR Nasdaq
- SERA Nasdaq
- Market Cap
- NATR 269.6M
- SERA 70.4M
- IPO Year
- NATR N/A
- SERA 2021
- Fundamental
- Price
- NATR $15.59
- SERA $2.49
- Analyst Decision
- NATR Strong Buy
- SERA
- Analyst Count
- NATR 2
- SERA 0
- Target Price
- NATR $18.50
- SERA N/A
- AVG Volume (30 Days)
- NATR 116.1K
- SERA 803.1K
- Earning Date
- NATR 08-07-2025
- SERA 08-06-2025
- Dividend Yield
- NATR N/A
- SERA N/A
- EPS Growth
- NATR N/A
- SERA N/A
- EPS
- NATR 0.53
- SERA N/A
- Revenue
- NATR $456,619,000.00
- SERA $115,000.00
- Revenue This Year
- NATR $3.08
- SERA $390.13
- Revenue Next Year
- NATR $2.41
- SERA $440.54
- P/E Ratio
- NATR $29.49
- SERA N/A
- Revenue Growth
- NATR 2.00
- SERA N/A
- 52 Week Low
- NATR $10.81
- SERA $1.37
- 52 Week High
- NATR $18.06
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- NATR 61.56
- SERA 53.89
- Support Level
- NATR $13.39
- SERA $1.82
- Resistance Level
- NATR $14.92
- SERA $4.09
- Average True Range (ATR)
- NATR 0.52
- SERA 0.36
- MACD
- NATR 0.02
- SERA 0.10
- Stochastic Oscillator
- NATR 94.50
- SERA 35.74
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.